Free Trial

Evotec (EVO) Stock Forecast & Price Target

$4.80
+0.09 (+1.91%)
(As of 07/26/2024 ET)

Evotec - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Based on 3 Wall Street analysts who have issued ratings for Evotec in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 3 analysts, 1 has given a hold rating, and 2 have given a buy rating for EVO.

Consensus Price Target

$11.00
129.17% Upside
High Forecast$11.00
Average Forecast$11.00
Low Forecast$11.00

According to the 3 analysts' twelve-month price targets for Evotec, the average price target is $11.00. The highest price target for EVO is $11.00, while the lowest price target for EVO is $11.00. The average price target represents a forecasted upside of 129.17% from the current price of $4.80.

TypeCurrent Forecast
7/28/23 to 7/27/24
1 Month Ago
6/28/23 to 6/27/24
3 Months Ago
4/29/23 to 4/28/24
1 Year Ago
7/28/22 to 7/28/23
Consensus Rating
Moderate Buy
Buy
Buy
N/A
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
N/A
Buy
2 Buy rating(s)
3 Buy rating(s)
3 Buy rating(s)
N/A
Hold
1 Hold rating(s)
0 Hold rating(s)
0 Hold rating(s)
N/A
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
N/A
Consensus Price Target$11.00$11.00$11.00N/A
Forecasted Upside129.17% Upside112.77% Upside110.33% UpsideN/A
Get Evotec Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for EVO and its competitors with MarketBeat's FREE daily newsletter.

EVO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

EVO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Evotec Stock vs. The Competition

TypeEvotecMedical CompaniesS&P 500
Consensus Rating Score
2.67
2.72
2.50
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside129.17% Upside3,123.46% Upside9.17% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
7/11/2024Deutsche Bank Aktiengesellschaft
2 of 5 stars
 DowngradeBuy ➝ Hold
5/23/2024HC Wainwright
3 of 5 stars
 Reiterated RatingBuy ➝ Buy$11.00 ➝ $11.00+112.77%
1/18/2024Royal Bank of Canada
4 of 5 stars
 UpgradeSector Perform ➝ Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 06:07 AM ET.

EVO Forecast - Frequently Asked Questions

What is Evotec's forecast for 2024?

According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for Evotec is $11.00, with a high forecast of $11.00 and a low forecast of $11.00.

Should I buy or sell Evotec stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Evotec in the last year. There is currently 1 hold rating and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" EVO shares.

Does Evotec's stock price have much upside?

According to analysts, Evotec's stock has a predicted upside of 112.77% based on their 12-month stock forecasts.

Has Evotec been downgraded by Wall Street analysts recently?

Over the previous 90 days, Evotec's stock had 1 downgrade by analysts.

What analysts cover Evotec?

Evotec has been rated by research analysts at Deutsche Bank Aktiengesellschaft, and HC Wainwright in the past 90 days.

Do Wall Street analysts like Evotec more than its competitors?

Analysts like Evotec less than other "medical" companies. The consensus rating score for Evotec is 2.67 while the average consensus rating score for "medical" companies is 2.72. Learn more on how EVO compares to other companies.


This page (NASDAQ:EVO) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners